BIOL

Biolase, Inc.
BIOL

Overview Fund Activity
Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

25 hedge funds and large institutions have $448K invested in Biolase, Inc. in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Prudential Financial
1
Prudential Financial
New Jersey
$27.4K
2
HF
2
HRT Financial
New York
$19K
3
VF
3
Virtu Financial
New York
$16K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$28K
5
TSS
5
Two Sigma Securities
New York
$7.24K

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
PCM
2
Perkins Capital Management
Minnesota
$30K
3
IA
3
IFP Advisors
Florida
$2K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$170K
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– – -17,549 Closed
Fidelity Investments
27
Fidelity Investments
Massachusetts
– – -41 Closed
PA
28
Parallel Advisors
California
– – -4 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 116 +55 +90%
1
2